PMC:7377212 / 17426-17644 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T135","span":{"begin":102,"end":107},"obj":"UBERON:0001977"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"LitCovid-PubTator","denotations":[{"id":"524","span":{"begin":158,"end":166},"obj":"Species"},{"id":"536","span":{"begin":86,"end":88},"obj":"Chemical"},{"id":"539","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A524","pred":"tao:has_database_id","subj":"524","obj":"Tax:9606"},{"id":"A536","pred":"tao:has_database_id","subj":"536","obj":"MESH:C012990"},{"id":"A539","pred":"tao:has_database_id","subj":"539","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T188","span":{"begin":204,"end":212},"obj":"Disease"}],"attributes":[{"id":"A188","pred":"mondo_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":27,"end":32},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T154","span":{"begin":47,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T155","span":{"begin":102,"end":105},"obj":"http://purl.obolibrary.org/obo/CLO_0002489"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T269","span":{"begin":19,"end":26},"obj":"Chemical"},{"id":"T270","span":{"begin":86,"end":88},"obj":"Chemical"}],"attributes":[{"id":"A269","pred":"chebi_id","subj":"T269","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A270","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A271","pred":"chebi_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"MyTest","denotations":[{"id":"32703771-28680526-29390917","span":{"begin":214,"end":216},"obj":"28680526"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T32","span":{"begin":86,"end":88},"obj":"GlycoEpitope"}],"attributes":[{"id":"A32","pred":"glyco_epitope_db_id","subj":"T32","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T90","span":{"begin":0,"end":218},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}

{"project":"2_test","denotations":[{"id":"32703771-28680526-29390917","span":{"begin":214,"end":216},"obj":"28680526"}],"text":"Novel lateral-flow antigen tests may represent a locally implementable alternative to GM ELISA in the CL3 laboratory, but currently require validation in ICU patients without EORTC host factors including COVID-19 [28]."}